美好医疗
(301363)
| 流通市值：88.90亿 | | | 总市值：135.55亿 |
| 流通股本：5.22亿 | | | 总股本：7.96亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,362,578,707.06 | 813,213,029.1 | 403,077,520.81 | 1,625,486,540.42 |
| 营业收入 | 1,362,578,707.06 | 813,213,029.1 | 403,077,520.81 | 1,625,486,540.42 |
| 二、营业总成本 | 1,071,162,589.02 | 658,047,574.57 | 337,442,473.35 | 1,273,131,275.66 |
| 营业成本 | 803,049,648.99 | 480,733,326.16 | 236,550,234.13 | 973,791,008.85 |
| 税金及附加 | 11,776,539.51 | 7,246,913.17 | 3,859,666.5 | 17,184,517.2 |
| 销售费用 | 29,914,742.38 | 18,924,835.94 | 11,686,607.75 | 47,365,924.01 |
| 管理费用 | 106,630,056.96 | 70,085,788.38 | 36,842,735.27 | 123,595,016.57 |
| 研发费用 | 98,725,882.56 | 63,008,357.68 | 36,245,285.95 | 133,823,843.76 |
| 财务费用 | 21,065,718.62 | 18,048,353.24 | 12,257,943.75 | -22,629,034.73 |
| 其中:利息费用 | 294,277.03 | 162,900 | 162,900 | 958,885.78 |
| 其中:利息收入 | 32,840,630.47 | 23,622,477.01 | 12,497,087.52 | 47,517,801.8 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,024,481.06 | 1,958,228.05 | 2,394,476.99 | -2,706,956.1 |
| 加:投资收益 | 3,727,639.24 | 1,968,474.02 | -152,733.73 | 6,611,789.25 |
| 资产处置收益 | -169,894.63 | -133,245.6 | -9,674.06 | 602,435.05 |
| 资产减值损失(新) | -24,544,774.72 | -17,421,093.11 | -5,421,674.22 | -38,981,197.26 |
| 信用减值损失(新) | -4,247,262.84 | 16,394.07 | 921,159.8 | -1,681,184.15 |
| 其他收益 | 4,271,417.02 | 3,282,493.61 | 1,913,575.99 | 8,997,169.98 |
| 四、营业利润 | 272,477,723.17 | 144,836,705.57 | 65,280,178.23 | 325,197,321.53 |
| 加:营业外收入 | 114,752.9 | 93,747.6 | 21,534.5 | 152,003.19 |
| 减:营业外支出 | 272,746.26 | 17,628.76 | 2.62 | 652,917.11 |
| 五、利润总额 | 272,319,729.81 | 144,912,824.41 | 65,301,710.11 | 324,696,407.61 |
| 减:所得税费用 | 38,678,582.94 | 20,588,749.05 | 8,618,109 | 41,615,435.71 |
| 六、净利润 | 233,641,146.87 | 124,324,075.36 | 56,683,601.11 | 283,080,971.9 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 233,641,146.87 | 124,324,075.36 | 56,683,601.11 | 283,080,971.9 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 233,641,146.87 | 124,324,075.36 | 56,683,601.11 | 283,080,971.9 |
| 扣除非经常损益后的净利润 | 228,253,943.54 | 120,270,469.21 | 54,345,840.37 | 277,490,686.6 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.29 | 0.16 | 0.1 | 0.5 |
| (二)稀释每股收益 | 0.29 | 0.16 | 0.1 | 0.5 |
| 八、其他综合收益 | -53,803,439.2 | -36,881,916.3 | -11,024,063.8 | 42,384,985.1 |
| 归属于母公司股东的其他综合收益 | -53,803,439.2 | -36,881,916.3 | -11,024,063.8 | 42,384,985.1 |
| 九、综合收益总额 | 179,837,707.67 | 87,442,159.06 | 45,659,537.31 | 325,465,957 |
| 归属于母公司股东的综合收益总额 | 179,837,707.67 | 87,442,159.06 | 45,659,537.31 | 325,465,957 |
| 公告日期 | 2026-10-23 | 2026-08-18 | 2026-04-21 | 2026-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |